¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Scleroderma, Limited"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® scleroderma ÇÑ±Û °øÇÇÁõ
¼³¸í   
  ¸¸¼ºÀûÀ¸·Î °è¼Ó ÁøÇàµÇ¾î ÇǺΰ¡ µÎ²¨¿ö Áö°í µüµüÇØÁö´Â º´À¸·Î, ¼Ò¾Æ¿Í ¾î¸¥¿¡°Ô¼­ ¸ðµÎ ¹ß»ýÇÒ ¼ö ÀÖ°í, Æ¯Â¡ÀûÀ¸·Î ¸ñ°ú µîÀÇ À­ºÎºÐ¿¡¼­ ½ÃÀ۵ǾƷ¡Âʰú ¾ÕÂÊÀ¸·Î ÆÛÁö´Â º´ÀÌ´Ù. À̰ÍÀº ÀÏÁ¾ÀÇ ÀÚ°¡¸é¿ªÁúȯ(ÀÚ½ÅÀÇ ¼¼Æ÷¸¦ À̹°Áú·Î ÀÎÁöÇÏ¿© ¸é¿ª¹ÝÀÀÀ» ÀÏÀ¸Å°´Â Áúȯ)À¸·Î »ý°¢µÇ¸ç, ÇǺοܿ¡ ¶ÇÇÑ ³»ºÎ±â°ü(¿¹¸¦ µé¾î ÄáÆÏ, ÇãÆÄ, ½Äµµ µî)¿¡µµ ¿ª½Ã °°Àº ¹ÝÀÀÀÌ ÀϾ´Ù. Ä¡·á´Â Æ¯ÀÌÇÑ °ÍÀº ¾ø°í, ¸é¿ª¾ïÁ¦Á¦ÀÇ Ä¡·á¿Í ¹°¸®Ä¡·á µîÀ» ÅëÇÑ °í½ÄÀûÄ¡·á¿¡ ±×Ä£´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • diffusion-limited transport
    È®»êÁ¦ÇÑ¿î¹Ý
  • limited flip angle
    Á¦ÇѼ÷ÀÓ°¢, Á¦ÇÑÀüÀ§°¢
  • pressure limited respirator
    ¾Ð·ÂÁ¦ÇÑÈ£Èí±â
  • pressure-limited ventilation
    ¾Ð·ÂÁ¦ÇÑȯ±â
  • pressure-limited ventilator
    ¾Ð·ÂÁ¦ÇÑÇüȯ±â±â
  • self-limited
    ÀÚ±âÇÑÁ¤-
  • self-limited disease
    ÀڱⱹÇѺ´
  • sex-limited
    ÇѼº-
  • circumscribed scleroderma
    ±¹ÇÑÇǺΰæÈ­Áõ, ±¹¼ÒÇǺΰæÈ­Áõ
  • diffuse scleroderma
    ±¤¹üÀ§ÇǺΰæÈ­Áõ
  • guttate scleroderma
    ¹æ¿ïÇǺΰæÈ­Áõ
  • linear scleroderma
    ¼±ÇǺΰæÈ­Áõ
  • localized scleroderma
    ±¹ÇÑÇǺΰæÈ­(Áõ)
  • scleroderma
    ÇǺΰæÈ­Áõ, ÇǺα»À½Áõ
  • scleroderma acrosclerosis
    ¸»´ÜÇǺΰæÈ­Áõ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • scleroderma
    ÇǺΰæÈ­Áõ, ÇǺα»À½Áõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • limited flip angle
    Á¦ÇѼ÷ÀÓ°¢, Á¦ÇÑÀüÀ§°¢
  • diffusion-limited transport
    È®»êÁ¦ÇÑ¿î¹Ý
  • sex limited disorder
    ÇѼºÀå¾Ö
  • pressure limited respirator
    ¾Ð·ÂÁ¦ÇÑÀΰøÈ£Èí±â
  • pressure-limited ventilation
    ¾Ð·ÂÁ¦ÇÑȯ±â
  • circumscribed scleroderma
    (¢¡localized scleroderma) ±¹ÇÑÇǺΰæÈ­Áõ
  • diffuse scleroderma
    ±¤¹üÀ§ÇǺΰæÈ­Áõ
  • guttate scleroderma
    ¹æ¿ïÇǺΰæÈ­Áõ
  • linear scleroderma
    ¼±»óÇǺΰæÈ­Áõ
  • localized scleroderma
    ±¹ÇÑÇǺΰæÈ­Áõ
  • scleroderma
    ÇǺΰæÈ­Áõ, ÇǺα»À½Áõ
  • scleroderma acrosclerosis
    ¸»´ÜÇǺΰæÈ­Áõ
  • scleroderma diabeticorum
    ´ç´¢º´ÇǺΰæÈ­Áõ
  • scleroderma en bande
    ¶ì¸ð¾çÇǺΰæÈ­Áõ
  • systemic scleroderma
    Àü½ÅÇǺΰæÈ­Áõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • guttate scleroderma
    ¹°¹æ¿ï °æÇÇÁõ
  • Flow-limited exchange
    À¯·®Á¦Çѱ³È¯(ð¤ùÚÎßüµ)
  • pressure limited respirator
    ¾Ð·ÂÁ¦ÇÑÀΰøÈ£Èí±â
  • pressure-limited ventilation
    ¾Ð·ÂÁ¦ÇÑȯ±â
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • diffusion-limited transport
    È®»êÁ¦ÇѼö¼Û
  • limited flip angle
    Á¦ÇÑÀû ÀüÀ§°¢
  • pressure limited respirator
    ¾Ð·ÂÁ¦ÇÑÀΰøÈ£Èí±â
  • pressure-limited ventilation
    ¾Ð·ÂÁ¦ÇÑȯ±â
  • sex limited disorders
    ÇѼºÀå¾Ö(ùÚàõî¡äô)
  • time-limited dynamic psychotherapy(TLDP)
    ½Ã°£Á¦ÇÑÀû ¿ªµ¿ Á¤½ÅÄ¡·á(ãÁÊàð¤ùÚîÜ æ³ÔÑ ïñãêö½Öû).
  • time-limited psychotherapy(TLP)
    ½Ã°£Á¦ÇÑÀû Á¤½Å¿ä¹ý.
  • volume sensitive respirator =v. limited r
    Á¦·®ÀΰøÈ£Èí±â, ¿ë·®Á¦ÇÑÀΰøÈ£Èí±â.
  • circumscribed scleroderma
    ±¹ÇѼº) °æÇÇÁõ
  • diffuse scleroderma
    ±¤¹üÀ§ ÇǺΠ°æÈ­Áõ
  • familial scleroderma
    °¡Á·¼º ÇǺΠ°æÈ­Áõ
  • guttate scleroderma
    ¹°¹æ¿ï °æÇÇÁõ
  • linear scleroderma
    ¼±»ó °æÇÇÁõ
  • localized scleroderma
    ±¹ÇѼº°æÇÇÁõ
  • scleroderma
    ÇǺΰæÈ­Áõ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • diffusion-limited reaction
    È®»êÁ¦ÇÑ ¹ÝÀÀ(üªß¤ð¤ùÚÚãëë)
  • limited chromosome
    Á¦ÇÑ¿°»öü(ð¤ùÚæøßäô÷)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • limited flip angle
    Á¦ÇÑÀû ÀüÀ§°¢
  • scleroderma
    ÇǺΰæÈ­Áõ, °æÇÇÁõ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DS dead air space; dead space; deep sedative; deep sleep; defined substrate; dehydroepiandrosterone sul...
LS lateral suspensor; left sacrum; left septum; left side; legally separated; leiomyosarcoma; length of...
LSc local scleroderma
PSS painful shoulder syndrome; physiologic saline solution; porcine stress syndrome; primary Sjogren syn...
SCD scleroderma; service-connected disability; sickle-cell disease; spinocerebellar degeneration; subacu...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
LJM Limited Joint Mobility
LD Limited disease
LSM Limited sampling models
Slp Sex-limited protein
LS Localized scleroderma
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • limited impairment
    Á¦ÇÑµÈ Àå¾Ö
  • self limited disease
    ÀÚ±â ÇÑÁ¤¼º Áúȯ
    Áúȯ ÀÚüÀÇ ¼ºÁú ¶§¹®¿¡ ÀÏÁ¤Çϰí ÇÑÁ¤µÈ °æ°í¸¦ ÃëÇÏ´Â Áúȯ.
  • circumscribed scleroderma
    ±¹ÇѼº °øÇÇÁõ
  • progressive scleroderma
    ÁøÇ༺ °øÇÇÁõ
  • scleroderma circumscripta
    ±¹ÇѼº °øÇÇÁõ
  • scleroderma in plaque
    ġų» °øÇÇÁõ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
progressive familial scleroderma A syndrome characterised by calcinosis cutis, Raynaud's phenomenon, sclerodactyly, and telangiectasia; usually due to scleroderma; autosomal dominant form of progressive systemic sclerosis.
(05 Mar 2000)
scleroderma <dermatology> Hardening of skin.
(04 Mar 1998)
scleroderma, circumscribed A chronic, localised hardening and thickening of the skin. Lesions may be categorised as morphea (guttate, profunda, pansclerotic) or linear (with or without melorheostosis or hemiatrophy). It is twice as common in women as in men. The condition is characterised by skin ischemia, lymphocytic infiltrates, swollen collagen bundles, and thickening of the dermis with reduction of subcutaneous fat.
(12 Dec 1998)
scleroderma, systemic A chronic, progressive dermatosis characterised by boardlike hardening and immobility of the affected skin, with visceral involvement, especially of lungs, oesophagus, kidneys and heart. It may be accompanied by calcinosis, raynaud's phenomenon, and telangiectasis (crest syndrome). It includes acrosclerosis and sclerodactyly.
(12 Dec 1998)
self-limited Denoting a disease that tends to cease after a definite period; e.g., pneumonia.
(05 Mar 2000)
self-limited disease A disease process that resolves spontaneously with or without specific treatment.
(05 Mar 2000)
sex-limited Occurring in one sex only.
See: sex-limited inheritance.
(05 Mar 2000)
sex-limited inheritance Inheritance of a trait that can be expressed in one sex only, e.g., testicular feminization.
(05 Mar 2000)
oesophagus: scleroderma <radiology> Females (80%), 35-55 years of age, decreased LES pressure, decreased peristalsis, smooth muscle atrophy with or without loose fibrosis, dermatomyositis may include involvement of upper 1/3 (striated), dysphagia to solids more than liquids (steakhouse syndrome), wide-open LES or HH, with or without basilar pulmonary fibrosis, other GI sites associated with CREST syndrome
(12 Dec 1998)
limited habitat A habitat type that is rare or has been significantly reduced from its historical distribution, either locally or statewide, and is of special importance meeting the general life requirements of many wildlife species.
(09 Oct 1997)
limited range audiometer A pure-tone audiometer designed to test restricted ranges of frequency and sound pressure.
(05 Mar 2000)
localised scleroderma A skin lesion that is characterised by the presence of localised, indurated, slightly depressed areas of thickened dermal tissue that may be white or yellow in colour and surrounded by a pink or purplish halo.
See: in cutaneus scleroderma.
(27 Sep 1997)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 1 ÆäÀÌÁö: 1
  • Scleroderma, Limited - »õâ The least progressive form of SYSTEMIC SCLERODERMA with skin thickening restricted to the FACE; NECK; and areas distal to the elbows and/or knees, sparing the trunk. The CREST SYNDROME is a form of limited scleroderma.
    Synonyms : Limited Scleroderma
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • limited
    Á¦ÇѵÈ
  • limited
    À¯ÇÑÀÇ;¾ó¸¶¾ÈµÇ´Â;Á¼Àº;~ war (Àû±ºÀÇ Àü¸éÀûÀÎ Ç׺¹À» ¸ñÀûÀ¸·Î ÇÏÁö ¾Ê´Â) ±¹ÁöÀü
  • limited company
    À¯ÇÑ Ã¥ÀÓ È¸»ç;ÁÖ½Äȸ»ç
  • limited edition
    ÇÑÁ¤ÆÇ
  • limited monarchy
    ÀÔÇ屺ÁÖÁ¤Ã¥
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á